Axial and gait disorders in Parkinson's Disease (PD) are considered signs of disease progression 53 with involvement of the extra nigrostriatal system. In PD patients treated with subthalamic nucleus 54 (STN) deep brain stimulation (DBS), these symptoms may also occur from spread of the electric 55 field outside the STN [1]. Various approaches have been suggested to manage gait disturbances [1 -56 3] and substantia nigra pars reticulata (SNr) DBS has recently been reported to improve resistant 57 freezing of gait (FoG) [4][5]. 58 We describe the case of a young-onset PD patient who developed left arm tremor at the age of 34 59 years. In 2005, after 10 years of disease progression, with troublesome wearing-off, resistant tremor 60 and disabling dyskinesias, he underwent bilateral 61 Medtronic, Minneapolis, MN, USA). Satisfactory control of motor symptoms was achieved with 62 DBS and optimization of oral therapy with rotigotine (16 mg/day) and levodopa (500 mg/day). 63 Postoperative MRI and initial stimulation parameters are shown in Fig. 1A. The implantable pulse 64 generator (IPG) was replaced in 2009 with Kinetra® (Medtronic, Minneapolis, MN, USA) and in 65 2013 with a Libra XP™ hybrid system (Abbott-St Jude Medical, Saint Paul, USA). Stimulation 66 parameters were not changed but switched from constant voltage (3.0 V) to constant current 67 stimulation (3.6 mA) in both electrodes, to maintain good control of motor symptoms. 68 Dopaminergic oral therapy was not modified. 69 In 2015, the patient developed rare FoG episodes. After overnight withdrawal, several observations 70 in this practical OFF medication condition suggested a major contribution of left leg in triggering 71 FoG. These FoG episodes were unresponsive to optimization of both best medical treatment 72 (levodopa [800 mg/day] and rotigotine [16 mg/day]) and modification of stimulation parameters 73 during an updated monopolar review in the right hemisphere testing the ventral and dorsal contacts 74 4 (9-and 12-). In addition, asymmetric stimulation by lowering the stimulation amplitude 75 contralaterally to the side with longer step length did not resolve FoG. 76 Because of battery depletion, a rechargeable IPG (Vercise™, Boston 77 Scientific, Marlborough, USA) was implanted in 2017, keeping the stimulation parameters constant 78 (Fig.1B). Over the following months, FoG became progressively disabling with occasional falls and 79 marked turn hesitation in the left leg (Video 1, segment 1). He scored 23/64 on the Gait and Falls 80
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(9-and 12-). In addition, asymmetric stimulation by lowering the stimulation amplitude 75 contralaterally to the side with longer step length did not resolve FoG.
IPG replacement using a device with multiple independent current control (MICC) allowed fine with contacts 10-and 11-(panel B; see also Video 1, segment 1) and after current steering along 230 contacts 9-, 10-, and 11-(panel C; see also Video 1, segment 3).
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On the left side of B and C, the contacts used and stimulation parameters can be seen. In the middle 232 panel of B and C, the VTA is shown in a 3D reconstruction. VTA is shown in red, STN in green, 233 and SNr in blue.
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On the right side, the VTA is shown in a 2D coronal (top) and axial slice view (bottom). Red lines:
